Probing midbrain dopamine function in pediatric obsessive-compulsive disorder via neuromelanin-sensitive magnetic resonance imaging

Obsessive-compulsive disorder (OCD) is an impairing psychiatric condition, which often onsets in childhood. Growing research highlights dopaminergic alterations in adult OCD, yet pediatric studies are limited by methodological constraints. This is the first study to utilize neuromelanin-sensitive MR...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular psychiatry 2023-07, Vol.28 (7), p.3075-3082
Hauptverfasser: Pagliaccio, David, Wengler, Kenneth, Durham, Katherine, Fontaine, Martine, Rueppel, Meryl, Becker, Hannah, Bilek, Emily, Pieper, Sarah, Risdon, Caroline, Horga, Guillermo, Fitzgerald, Kate D., Marsh, Rachel
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Obsessive-compulsive disorder (OCD) is an impairing psychiatric condition, which often onsets in childhood. Growing research highlights dopaminergic alterations in adult OCD, yet pediatric studies are limited by methodological constraints. This is the first study to utilize neuromelanin-sensitive MRI as a proxy for dopaminergic function among children with OCD. N  = 135 youth (6–14-year-olds) completed high-resolution neuromelanin-sensitive MRI across two sites; n  = 64 had an OCD diagnosis. N  = 47 children with OCD completed a second scan after cognitive-behavioral therapy. Voxel-wise analyses identified that neuromelanin-MRI signal was higher among children with OCD compared to those without (483 voxels, permutation-corrected p  = 0.018). Effects were significant within both the substania nigra pars compacta ( p  = 0.004, Cohen’s d  = 0.51) and ventral tegmental area ( p  = 0.006, d  = 0.50). Follow-up analyses indicated that more severe lifetime symptoms ( t  = −2.72, p  = 0.009) and longer illness duration ( t  = −2.22, p  = 0.03) related to lower neuromelanin-MRI signal. Despite significant symptom reduction with therapy ( p  
ISSN:1359-4184
1476-5578
DOI:10.1038/s41380-023-02105-z